1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (585) 273-1042.
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Article first published online: 4 OCT 2007
DOI: 10.1002/cncr.23062
Copyright © 2007 American Cancer Society
Additional Information
How to Cite
Khorana, A. A., Francis, C. W., Culakova, E., Kuderer, N. M. and Lyman, G. H. (2007), Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer, 110: 2339–2346. doi: 10.1002/cncr.23062
Publication History
- Issue published online: 2 NOV 2007
- Article first published online: 4 OCT 2007
- Manuscript Accepted: 29 MAY 2007
- Manuscript Revised: 22 MAY 2007
- Manuscript Received: 3 APR 2007
Funded by
- National Cancer Institute. Grant Number: 1K23 CA120587-01A1
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer, Cancer, 2012, 118, 11Direct Link:
- 2, , , , , , , , , Androgen deprivation and thromboembolic events in men with prostate cancer, Cancer, 2012, 118, 11Direct Link:
- 3
- 4, Cancer and coagulation, American Journal of Hematology, 2012, 87, S1Direct Link:
- 5, , , , , , , , , Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients—a pilot study, Supportive Care in Cancer, 2012,
- 6
- 7, , , , , , Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study, Journal of Thrombosis and Thrombolysis, 2012,
- 8, , , , , , , Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: Results from a prospective cohort study with Asian population, Thrombosis Research, 2012,
- 9, , Lung cancer associated venous thromboembolic disease: A comprehensive review, Lung Cancer, 2012, 75, 1, 1
- 10, Predicting and accounting for VTE in phase I cancer studies, Annals of Oncology, 2012, 23, 6, 1373
- 11, , , , Qu’en est-il des décès en garde à vue à Abidjan ? Étude rétrospective sur 8ans (2001–2008), La Revue de Médecine Légale, 2012, 3, 1, 27
- 12, , , Risk assessment models for cancer-associated venous thromboembolism, Cancer, 2012, 118, 11Direct Link:
- 13, , , , , , , , , , Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer, New England Journal of Medicine, 2012, 366, 7, 601
- 14, , , , The thrombophilic state in cancer part II: Cancer outcomes, occult malignancy, and cancer suppression, Journal of Surgical Oncology, 2012, 105, 8Direct Link:
- 15, , , Treating venous thromboembolism in patients with cancer, Expert Review of Hematology, 2012, 5, 2, 201
- 16, , , , , , , , Venous thromboembolism (VTE) in patients with advanced gastric cancer: An Asian experience, European Journal of Cancer, 2012, 48, 4, 492
- 17, , , , All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells, Thrombosis Research, 2011, 128, 4, 368
- 18, , Anticoagulant use in cancer patients, Expert Opinion on Pharmacotherapy, 2011, 12, 3, 351
- 19, , Cancer-associated thrombosis: an update, Drug Discovery Today: Disease Mechanisms, 2011, 8, 1-2, e39
- 20, , , , Clinical Use of the Low-Molecular-Weight Heparins in Cancer Patients: Focus on the Improved Patient Outcomes, Thrombosis, 2011, 2011, 1
- 21, , Epidemiology, risk and outcomes of venous thromboembolism in cancer, Hämostaseologie, 2011, 32, 2, 115
- 22, , , , , , , , Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center, Cancer, 2011, 117, 16Direct Link:
- 23, , , , , , , , , , , , , , , , , , , Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide, Leukemia & Lymphoma, 2011, 52, 5, 776
- 24, , , , , , , , , , , Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer, Thrombosis and Haemostasis, 2011, 105, 6, 962
- 25, , Maladie veineuse thromboembolique et cancer, Revue des Maladies Respiratoires, 2011, 28, 4, 443
- 26, , , , Microparticles, malignancy and thrombosis, British Journal of Haematology, 2011, 152, 6Direct Link:
- 27, , , , , Myocardial infarction, ischaemic stroke and pulmonary embolism before and after breast cancer hospitalisation, Thrombosis and Haemostasis, 2011, 106, 1, 149
- 28, , Prevention of venous thromboembolism in cancer patients: current approaches and opportunities for improvement, Oncology Reviews, 2011, 5, 3, 191
- 29
- 30, , , , , , , Rates of Venous Thromboembolism Among Patients with Major Surgery for Cancer, Annals of Surgical Oncology, 2011, 18, 12, 3240
- 31, , , , , , , , , Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer, Annals of Oncology, 2011, 22, 11, 2394
- 32, , Risk of venous thromboembolism and primary prophylaxis in cancer, Hämostaseologie, 2011, 32, 2, 132
- 33, , , , , Role of Factor Xa Inhibitors in Cancer-Associated Thrombosis: Any New Data?, Advances in Hematology, 2011, 2011, 1
- 34, , , , , Saddle Pulmonary Embolism in a Cancer Patient with Thrombocytopenia: A Treatment Dilemma, Cardiology Research and Practice, 2011, 2011, 1
- 35, , , , , Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer, Thrombosis and Haemostasis, 2011, 106, 2, 371
- 36, , The association of cancer and venous thrombosis: yes, Trousseau is right … again!, Leukemia & Lymphoma, 2011, 52, 5, 734
- 37, , , , Thrombophilic state in cancer, Part I: Biology, incidence, and risk factors, Journal of Surgical Oncology, 2011, 104, 3Direct Link:
- 38, Venous thromboembolism in the patient with cancer, Cancer, 2011, 117, 7Direct Link:
- 39, , , , , , , A Computerized Prompt for Thromboprophylaxis in Hospitalized Cancer Patients, Thrombosis Research, 2010, 126, 1, 32
- 40, Acquired thrombotic risk factors in the critical care setting, Critical Care Medicine, 2010, 38, S43
- You have free access to this content41, , Application of thrombelastography/thromboelastometry to veterinary medicine, Veterinary Clinical Pathology, 2010, 39, 4Direct Link:
- 42, , , , Cancer in males and risk of venous thromboembolism, Thrombosis Research, 2010, 125, S155
- 43, , Cancer Patients and Awareness of Venous Thromboembolism, Cancer Investigation, 2010, 28, 1, 44
- 44, , , , , , , , , Early detection of venous thromboembolism in patients with neuroepithelial tumor: efficacy of screening with serum d-dimer measurements and Doppler ultrasonography, Journal of Neuro-Oncology, 2010, 101, 3, 495
- 45, , Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score, Thrombosis Research, 2010, 125, S1
- 46, , Epidemiology of thrombotic risk factors: The difficulty in using clinical trials to develop a risk assessment model, Critical Care Medicine, 2010, 38, S10
- 47, , , , , , , , , , High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS), Journal of Thrombosis and Haemostasis, 2010, 8, 1Direct Link:
- 48, , , , High rates of symptomatic and incidental thromboembolic events in gastrointestinal cancer patients, Journal of Thrombosis and Haemostasis, 2010, 8, 8Direct Link:
- 49, , , , , , , , Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006, British Journal of Cancer, 2010, 103, 7, 947
- 50, , , , , , , Lessons from French national guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients, Thrombosis Research, 2010, 125, S108
- 51, Prévention et traitement de l’embolie pulmonaire au cours du cancer, Revue des Maladies Respiratoires Actualités, 2010, 2, 3, 259
- 52, , , , , , , , , Prediction of venous thromboembolism in cancer patients, Blood, 2010, 116, 24, 5377
- 53, , Prostate-cancer-associated hypercoagulability: do we need to worry about androgen deprivation?, The Lancet Oncology, 2010, 11, 5, 406
- 54, , , , , , , , , , Risk factors for cancer-associated venous thromboembolism in outpatient deep venous thrombosis clinics, British Journal of Haematology, 2010, 150, 5Direct Link:
- 55, , , , , Statins Decrease the Occurrence of Venous Thromboembolism in Patients with Cancer, The American Journal of Medicine, 2010, 123, 1, 60
- 56, , The role of thromboprophylaxis in cancer patients: emerging data, Current Opinion in Hematology, 2010, 17, 5, 450
- 57, , , , , , , , Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events, Blood, 2010, 115, 26, 5322
- 58, , , , , , Unsuspected Pulmonary Emboli in Oncology Patients Undergoing Routine Computed Tomography Imaging, Journal of Thoracic Oncology, 2010, 5, 6, 798
- 59
- 60, , Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma, Thrombosis Research, 2010, 125, S96
- 61
- 62, A step in the right direction, but one size might not fit all, The Lancet Oncology, 2009, 10, 10, 930
- 63, Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: A review of current guidelines, Cancer Treatment Reviews, 2009, 35, 8, 754
- 64, , , , , Audit of anticoagulant thromboprophylaxis in hospitalized oncology patients, Internal Medicine Journal, 2009, 39, 12Direct Link:
- 65
- 66, , Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model, Thrombosis Research, 2009, 123, S18
- 67, , Epidemiology of cancer-related venous thromboembolism, Best Practice & Research Clinical Haematology, 2009, 22, 1, 9
- 68, , Management of Venous Thromboembolism and the Potential to Impact Overall Survival in Patients with Cancer, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009, 29, 11Direct Link:
- 69, , , , , , , , , , , , , , , , Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study, The Lancet Oncology, 2009, 10, 10, 943
- 70, , , , Predictors of Venous Thromboembolism in Patients with Advanced Common Solid Cancers, Journal of Cancer Epidemiology, 2009, 2009, 1
- 71, , Risk stratification for cancer-associated venous thromboembolism, Best Practice & Research Clinical Haematology, 2009, 22, 1, 35
- 72, , , , , , , , , , , , , , , , Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma, Blood, 2009, 114, 4, 772
- 73, , , , The role of community oncologists in the prevention and treatment of VTE: clinical guidelines and CMS payment policy, Community Oncology, 2009, 6, 12, 563
- 74, Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer, Cancer, 2009, 115, 24Direct Link:
- 75, , Use of deep vein thrombosis prophylaxis in hospitalized cancer patients, Blood Coagulation & Fibrinolysis, 2009, 20, 7, 571
- 76, , , , , Venous Thromboembolism in Lymphoma, American Journal of Clinical Oncology, 2009, 32, 5, 521
- 77, , A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism, European Journal of Oncology Nursing, 2008, 12, 5, 425
- 78, , , , , Endovascular stenting for the management of port-a-cath associated superior vena cava syndrome, Emergency Radiology, 2008, 16, 2, 143
- 79, , , Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients, Cancer, 2008, 113, 1Direct Link:
- 80, , , , , , Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation, Journal of Thrombosis and Haemostasis, 2008, 6, 9Direct Link:
- 81, , , , , , , , , Long-term use of daily subcutaneous low molecular weight heparin in cancer patients with venous thromboembolism: why hesitate any longer?, Supportive Care in Cancer, 2008, 16, 12, 1333
- 82, , , Reply to Frequency, Risk Factors, and Trends for Venous Thromboembolism Among Hospitalized Cancer Patients, Cancer, 2008, 113, 1Direct Link:
- 83, , , , , , Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival, Blood, 2008, 113, 17, 3911
- 84, , Approaches to risk-stratifying cancer patients for venous thromboembolism, Thrombosis Research, 2007, 120, S41